Dr John Melki – CEO and Director – Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
Copyright 2023 – Finance News Network
Source: Finance News Network
13 Feb 2024 - Novonix Limited (ASX:NVX) CEO Dr Chris Burns discusses the significance of the company's binding offtake agreement with Panasonic.
Read More06 Apr 2020 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its new drug application with the US FDA for Technegas and applications beyond pulmonary embolism in chronic chronic obstructive pulmonary ( COPD ) and asthma.
Read More05 May 2022 - Elementos Limited (ASX:ELT) Managing Director Joe David discusses factors behind the recent increase in the tin price and outlines Elementos' key project in Oropesa, Spain.
Read More17 Jan 2022 - eCargo Holdings Limited (ASX:ECG) Head of Corporate Marketing Lewis Bacon provides an insight into how eCommerce will continue to grow in China and across Asia, and eCargo’s position to assist brands with market entry.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More27 Jul 2022 - TerraCom Limited (ASX:TER) Managing Director Danny McCarthy discusses highlights of the company's June quarter results, the recent rains in Queensland, the mine life and run rate of the company's key asset Blair Athol and the outlook for coal.
Read More28 Aug 2019 - Ingenia Communities Group Limited (ASX:INA) CFO, Scott Noble discusses the company's FY19 results, its portfolio and the demand for seniors' accommodation.
Read More15 Jul 2020 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director James Graham provides an update on positive data against a range of persistent bacteria using the company's synthetic antibiotic RECCE 327, commencement of Phase I human clinical trial in 2H20 and key priorities.
Read More25 Jul 2024 - Alex Dorsch - CEO & Managing Director - Chalice Mining (ASX:CHN) is advancing the Gonneville Project—a major 2020 discovery in Western Australia with critical metals like platinum, nickel, and copper—towards development. The project boasts a tier-1 Mineral Resource Estimate, significant land in the new West Yilgarn Ni-Cu-PGE Province, and has earned multiple awards, including the 2023 Thayer Lindsley Award.
Read More27 May 2021 - QEM Limited (ASX:QEM) Managing Director Gavin Loyden discusses the invention and advantages of vanadium redox flow batteries with Professor Maria Skyllas-Kazacos of the University of New South Wales.
Read More
